Claire Poll - 01 Nov 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Signature
/s/ Claire Poll
Issuer symbol
VRNA
Transactions as of
01 Nov 2023
Net transactions value
-$303,254
Form type
4
Filing time
03 Nov 2023, 20:09:56 UTC
Previous filing
24 Oct 2023
Next filing
05 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Tax liability $303,254 -173,904 -8.6% $1.74* 1,843,487 01 Nov 2023 Direct F1, F2, F3
transaction VRNA Ordinary Shares Gift $0 -196,096 -11% $0.000000 1,647,391 01 Nov 2023 Direct F1, F4
transaction VRNA Ordinary Shares Gift $0 +196,096 +23% $0.000000 1,060,328 01 Nov 2023 By Trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2023 divided by eight (8).
F4 Consists of (i) 1,301,672 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 162,709 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs and (iii) 7 Ordinary Shares.
F5 Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.